Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Mar 09, 2020 2:08pm

161 Views

Post# 30784303

RE:RE:RE:RE:RE:Sound Familiar !

datawork/Mikee - blue light cystoscopy has been around a while and is expanding.It is an effective treatment that reduces the amount of required re-treatments (from around 35% to 10% according to the link below which I seem to remember posting a year or so back).

https://www.pelicancancer.org/patient-resources/bladder-cancer/blue-light-cystoscopy/?doing_wp_cron=1583776656.5438098907470703125000

Still plenty of room for TLT in this indication and indeed many others (mouth,throat gullet,cervix etc.) but it is likely to be with Rutherrin and non-superficial cancers that the Company`s true potential becomes more widely appreciated.

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism